purinergic P2Y receptor antagonists

Preferred Label : purinergic P2Y receptor antagonists;

MeSH definition : Compounds that bind to and block the stimulation of PURINERGIC P2Y RECEPTORS. Included under this heading are antagonists for specific P2Y receptor subtypes.;

MeSH synonym : P2Y purinoceptor antagonists; antagonists, P2Y purinoceptor; purinoceptor antagonists, P2Y; P2Y Purinoceptor Antagonist; Antagonist, P2Y Purinoceptor; Purinoceptor Antagonist, P2Y; Purinergic P2Y Receptor Antagonist;

CISMeF synonym : blockers, ADP receptor;

MeSH hyponym : purinergic P2Y1 receptor antagonists; purinergic P2Y2 receptor antagonists; purinergic P2Y12 receptor antagonists; adenosine diphosphate receptor antagonists; P2Y1 Purinoceptor Antagonists; Antagonists, P2Y1 Purinoceptor; Purinoceptor Antagonists, P2Y1; P2Y2 Purinoceptor Antagonists; Antagonists, P2Y2 Purinoceptor; Purinoceptor Antagonists, P2Y2; ADP Receptor Blockers; Receptor Blockers, ADP; ADP Receptor Antagonists; Antagonists, ADP Receptor; Receptor Antagonists, ADP; P2Y12 Receptor Antagonists; Antagonists, P2Y12 Receptor; Receptor Antagonists, P2Y12; P2Y12 Purinoceptor Antagonists; Antagonists, P2Y12 Purinoceptor; Purinoceptor Antagonists, P2Y12; Purinergic P2Y1 Receptor Antagonist; P2Y1 Purinoceptor Antagonist; Antagonist, P2Y1 Purinoceptor; Purinoceptor Antagonist, P2Y1; Purinergic P2Y2 Receptor Antagonist; P2Y2 Purinoceptor Antagonist; Antagonist, P2Y2 Purinoceptor; Purinoceptor Antagonist, P2Y2; ADP Receptor Antagonist; Antagonist, ADP Receptor; Receptor Antagonist, ADP; Adenosine Diphosphate Receptor Antagonist; ADP Receptor Blocker; Blocker, ADP Receptor; Receptor Blocker, ADP; P2Y12 Purinoceptor Antagonist; Antagonist, P2Y12 Purinoceptor; Purinoceptor Antagonist, P2Y12; Purinergic P2Y12 Receptor Antagonist; P2Y12 Receptor Antagonist; Antagonist, P2Y12 Receptor; Receptor Antagonist, P2Y12;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D058921;

UMLS CUI

C2936583;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Indexing information
- 1-(2-(1'-neopentylspiro(indoline-3,4'-piperidine)-1-yl)phenyl)-3-(4-(trifluoromethoxy)phenyl)urea [MeSH Supplementary Concept]
- 2-chloro-N6-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate [MeSH Supplementary Concept]
- ethyl 6-(4-((benzylsulfonyl)carbamoyl)piperidin-1-yl)-5-cyano-2-isopropylnicotinate [MeSH Supplementary Concept]
MeSH Descriptor(s) used for indexing
- receptors, purinergic P2Y [MeSH Descriptor]
- receptors, purinergic P2Y1 [MeSH Descriptor]
- receptors, purinergic P2Y12 [MeSH Descriptor]
- receptors, purinergic P2Y2 [MeSH Descriptor]
Record concept(s)
- adenosine diphosphate receptor antagonists [MeSH concept]
- purinergic P2Y receptor antagonists [MeSH concept]
- purinergic P2Y1 receptor antagonists [MeSH concept]
- purinergic P2Y12 receptor antagonists [MeSH concept]
- purinergic P2Y2 receptor antagonists [MeSH concept]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- ARC 118925XX [MeSH Supplementary Concept]
- Clopidogrel [MeSH Descriptor]
- N(6)-methyl-2'-deoxyadenosine 3',5'-diphosphate [MeSH Supplementary Concept]
- Ticagrelor [MeSH Descriptor]
- cangrelor [MeSH Supplementary Concept]
- clopidogrel carboxylic acid [MeSH Supplementary Concept]
- ticlopidine [MeSH Descriptor]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients